Table 2.
Age | 10% RRR† | 15% RRR | 20% RRR | Range 20%‡ | 25% RRR | 30% RRR |
---|---|---|---|---|---|---|
40 | 11050 | 7370 | 5530 | 2820–11630 | 4420 | 3680 |
45 | 7700 | 5130 | 3850 | 1980–8070 | 3080 | 2570 |
50 | 5950 | 3970 | 2970 | 1540–6160 | 2380 | 1980 |
55 | 5000 | 3330 | 2500 | 1320–5100 | 2000 | 1670 |
60 | 4460 | 2970 | 2230 | 1200–4450 | 1780 | 1490 |
65 | 4120 | 2750 | 2060 | 1130–4020 | 1650 | 1370 |
* Number of examinations is 5.25 times the number need to screen repeatedly (NNSR), which is the reciprocal of the reduction in absolute death risk (RADR) in Figure 1. The number needed to screen once (NNSO) is equivalent to the number of examinations if the benefit is the same for all mammograms. The average benefit of a subsequent screen is the inverse of the NNSO.
† The 5.25 median screens from the trials are responsible for the relative risk reduction (RRR) for repeated screening. We assumed the baseline exam has twice the benefit of a subsequent exam [11,29,33].
‡ The range is calculated by using interval analysis.